DLA Commercial Solutions Opening (CSO) FY2026
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DCSO PHILADELPHIA
Contract Value
Not provided
Codes & Classification
Solicitation Number
SP4701-24-S-C001
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AC33
Additional Details
The Defense Logistics Agency (DLA), under the Department of Defense, has issued a Commercial Solutions Opening (CSO) solicitation (Procurement Identifier: SP4701-24-S-C001) for Fiscal Year 2026. This CSO, authorized by 10 U.S.C. § 3458 and implemented through the Defense Federal Acquisition Regulation Supplement (DFARS) Subpart 212.70, is designed to solicit innovative commercial solutions that address specific Areas of Interest (AOIs) relevant to DLA’s mission of providing worldwide logistical support to military services and other authorized customers, including civilian organizations and foreign entities.
**Purpose, Scope, and Intended Outcomes**
The primary objective of this CSO is to identify and acquire cutting-edge commercial technologies and services that can enhance DLA’s logistics operations. The CSO is structured to remain open until October 1, 2026, though DLA reserves the right to amend, open, or close AOIs at its discretion. Offerors are encouraged to monitor the CSO regularly for updates or new AOIs. The intended outcome is to foster innovation and streamline the acquisition of solutions that address DLA’s evolving operational needs.
**Key Requirements, Objectives, and Expected Deliverables**
Offerors are invited to submit unclassified Solution Briefs electronically, using the provided template, in response to published AOIs. Each Solution Brief must be self-contained, as DLA will not consider external references, supplementary materials, or links. Proprietary information should be clearly marked, and all submissions must comply with DFARS 252.227-7016 regarding rights in bid or proposal information. Solution Briefs must remain valid for 180 calendar days from the date of submission.
Multiple Solution Briefs may be submitted for each AOI, but each will be evaluated independently. The evaluation process is multi-phased:
1. **Conformance Review:** Initial screening for compliance with CSO requirements.
2. **Technical Evaluation:** Subject-matter experts assess Solution Briefs based on five factors:
- **Possibility of Funding:** Availability of funds and cost competitiveness.
- **Technical Feasibility:** Alignment with current technology and science, favoring lower risk.
- **Responsiveness:** Direct relevance to the AOI without introducing new issues.
- **Viability:** Compatibility with existing DLA, DoD, and federal policies and procedures.
- **Desirability:** Adaptability, usefulness, and ease of implementation for end-users.
Only Solution Briefs rated as “Funding Possible” will proceed to further evaluation. Highly rated solutions may be invited for a Pitch (presentation), submission of a Full Proposal, or directly to award negotiations. The process is designed to be flexible, allowing DLA to select the most promising solutions for further consideration and potential contract award.
**Contracting Entity and Contact Information**
- **Contracting Entity:** DCSO Philadelphia, Defense Logistics Agency
- **Location:** Philadelphia, Pennsylvania, United States
- **NAICS Code:** 541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- **Product Service Code:** AC33
- **Primary Contact:** Mr. Thomas J. Walsh, Agreements and Contracting Officer ([email protected], 215-737-5466)
- **Secondary Contact:** Mrs. Lauren Runowski, Agreements and Contracting Specialist ([email protected])
**Procurement Type, Set-Aside Requirements, and Special Considerations**
This solicitation is a CSO, which allows for the acquisition of commercial items and services through a streamlined process. Awards under this CSO will generally be fixed-price contracts in accordance with DFARS 212.7002(b), though DLA may also utilize Other Transaction Agreements (OTAs) under 10 U.S.C. § 4022 at its discretion. No set-aside requirements are specified in the notice. Importantly, DLA does not provide funding for proposal preparation; funding is only available upon execution of a contract or agreement.
Offerors should note that DLA can only award contracts to responsible entities as defined in FAR Part 9. Additionally, Chapter 21 of Title 41, United States Code, applies to all proposals and contracts awarded under this CSO, regardless of the acquisition vehicle.
**Constant Elements Over the Contract Lifecycle**
- The CSO will remain open until October 1, 2026, unless closed earlier by DLA.
- AOIs may be updated or amended at DLA’s discretion.
- All submissions must adhere to the specified format and evaluation criteria.
- Only responsible entities are eligible for award.
- No funding is provided for proposal preparation; funding is contingent upon contract award.
- The evaluation process and award procedures, including the possibility of follow-on production contracts for successful OTAs, will remain consistent throughout the CSO period.
**Relevant Attachments and AOIs**
The solicitation includes several attachments and addendums, such as the Solution Brief Application (conformed through various amendments) and detailed descriptions of current AOIs, which include:
- Direct Vendor Delivery Tracking (DVDT)
- Emerging Engineering Services for Technical Data (multiple AOIs and supplemental information)
- Decision Analytics, Operational Planning, and Predictive and Probabilistic AI Modeling
Interested contractors should review these documents for specific technical requirements and submission instructions.
**Conclusion**
This CSO represents a significant opportunity for commercial entities specializing in research and development within the physical, engineering, and life sciences domains to partner with DLA in advancing logistics capabilities. The flexible, innovation-focused procurement approach is well-suited for organizations with novel solutions that can address DLA’s operational challenges. Prospective offerors are encouraged to carefully review the solicitation, monitor for updates, and ensure compliance with all submission and evaluation requirements.
For further information or to submit Solution Briefs, contact Mr. Thomas J. Walsh or Mrs. Lauren Runowski at the provided email addresses.
Documents14